Register | Login
Intellectual Property Today
RFC Express - Document Management System
2013 Top Patent Firms
2013 Top Trademark Firms
Current Issue
_blank

Advertising Opportunities

Click Here

Email A Friend Back to Archived News


MicroFluidic Systems Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis


Wednesday, June 17, 2009

Fremont, CA -- Microfluidic Systems, a privately-held company, announced today that they received patent number 7,541,166, entitled "Sonication to Selectively Lyse Different Cell Types". This method, originally applied to the process of differential extraction of male/female DNA from a mixed forensic sample, has broad application in a wide variety of biological sample processes for analysis and identification. Combined with the companion patent number 7,491,527, "Microfluidic Differential Extraction Cartridge", it provides a complete solution to automate this complex sample processing method. The differential extraction technique is a key step in the identification of the perpetrator's DNA of a rape from a forensic sample. Performing this method in a closed, disposable, and automated cartridge ensures sample integrity and prevents human error, which is important to providing legal evidence in pursuing crimes. Similar requirements are pervasive in all biological sample processing applications.

"MFSI is pleased to further establish its proprietary position in this important sample processing technique," commented Dr. M. Allen Northrup, MFSI President and CEO. "It adds to our repertoire of microfluidic solutions to complex biological processing and analysis products," he added.

MicroFluidic Systems (MFSI), www.microfluidicsystems.com, was founded in 2001 and is focused on the development of microfluidic systems for automated preparation of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for the US Government and commercial markets for over 20 years, including the world's first miniaturized, portable, battery-operated, real-time, polymerase-chain-reaction (PCR)-based detection system. For more information, please contact MFSI at 510-354-0400 or visit the website, www.microfluidicsystems.com.

Statements in this press release are forward-looking. Actual results might differ from these statements due to unforeseen events and uncertainties. MFSI disclaims any intention to or obligation to update these forward-looking statements.



Back to Archived News
Looking for...

  © Copyright 2013 Intellectual Property Today
Download Adobe Reader for free